Mumbai, June 30 -- Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has restarted the production at its Penicillin-G
manufacturing facility, at Kakinada, Andhra Pradesh with immediate effect, after receiving the consent to operate from Andhra Pradesh Pollution Control Board on 29 June 2025.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.